Last reviewed · How we verify

NCT03948139

Femur Fracture: Functional Bracing vs. Hip Spica Cast

Completed NA Last updated 5 March 2025
What this trial tests

NA trial testing Functional Brace in Pediatric Femur Fracture in 92 participants. Completed in 11 February 2025.

Timeline
16 October 2018
Primary endpoint
19 June 2023
11 February 2025

Quick facts

Lead sponsorChildren's Hospital Los Angeles
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment92
Start date16 October 2018
Primary completion19 June 2023
Estimated completion11 February 2025
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Children's Hospital Los Angeles

Who can join

Under 5, any sex, with Pediatric Femur Fracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Spica casting is the current standard of care when treating pediatric diaphyseal femur fractures in the 0-5 year age group. A study conducted by Kramer et al. suggests there are both clinical and financial benefits of functional bracing when compared to spica casting. To this date there have been no prospective trials to evaluate these two treatment options. The investigators plan to conduct a multi-center randomized-control trial that will compare the subjective, objective and financial aspects of functional bracing and spica casting for pediatric femur fractures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Children's Hospital Los Angeles trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03948139.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing